Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab add-on therapy for airway inflammation and remodeling in moderate to severe allergic asthma
2007-004653-29Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and allergic asthma comparing Omalizumab add-on with Placebo add-on (2 arms). Started Jan 2008; status: completed.
02
Drugs
omalizumab
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2007-004653-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004653-29.